Teladoc Health Investor Presentation — January 2021

Document content

1Q-21 Quarterly Results

••Revenue of $454M grew 151% y/y

•Adjusted EBITDA of $56.6M grew 430% y/y

•FY-21 Revenue guidance range raised to $1,970M to $2,020M, up from $1,950M to $2,000M

•2Q-21 Revenue guidance range $495M to $505M

•FY-21 Adj. EBITDA guidance range maintained at $255M to $275M

•2Q-21 Adj. EBITDA guidance range $61M to $64M

1. See reconciliation of GAAP to non -GAAP measures immediately following this presentation.

2. Adjusted EBITDA for 1Q -21 and Adj. EBITDA guidance for 2Q -21 and FY -21 includes benefit from lower expenses on Livongo devices a ttributable to purchase accounting adjustments related to the merger of $6.9M, $6M and

$20M, respectively. •Signed significant expansion of our relationship with a regional Blues plan in the East,

including Teladoc becoming the standard provider of telehealth services for Commercial

plans and the addition of a full suite of whole -person chronic care solutions

•Continued progress on integration of Teladoc and Livongo, including enabling Teladoc

physician referrals into chronic care programs

•% of chronic care members enrolled in more than one program has grown more than 3x

year -over year to >15%

•Continued robust growth of utilization for non -infectious diseases and specialty visits such

as mental health and dermatology

•Claus Jensen joined executive team as Chief Innovation OfficerAdj. EBITDA ($ millions)(1) (2) Revenue ($ millions)

$0$10$20$30$40$50$60

$0$100$200$300$400$500

1. See reconciliation of GAAP to non -GAAP measures immediately following this presentation

2. 1Q-21 Adjusted EBITDA includes $6.9M benefit from lower expenses on Livongo devices attributable to purchase accounting adjustme nts related to the merger. Access Fee Revenue ($ millions) Visit Fee Revenue ($ millions)

$0$100$200$300$400$500

$0$10$20$30$40$50$60

1Q-20 1Q-21U.S. Revenue ($ millions) International Revenue ($ millions)

$0$100$200$300$400$500

1Q-20 1Q-21U.S. Paid Members (millions) Revenue ($ millions)

PMPM Chronic Care Enrollment (000s)43.050.0 50.0 50.3 51.51.5 1.5 1.5

1Q-20 2Q-20 3Q-20 4Q-20 1Q-21

Preview truncated — download the full document for the complete content.